A Pilot Study of Celecoxib in Patients With Grade 2 or 3 Uterine Cancers
This study has been terminated.
(Due to reported toxicity of Celecoxib at high doses)
Sponsor:
Mark H. Einstein
Collaborator:
Pharmacia
Information provided by (Responsible Party):
Mark H. Einstein, Montefiore Medical Center
ClinicalTrials.gov Identifier:
NCT00231829
First received: September 30, 2005
Last updated: April 22, 2012
Last verified: April 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been terminated. |
|---|---|
| Study Completion Date: | March 2004 |
| Primary Completion Date: | March 2004 (Final data collection date for primary outcome measure) |